Pasithea Therapeutics Corp. (KTTA)

USD 1.4

(-7.89%)

Total Debt Summary of Pasithea Therapeutics Corp.

  • Pasithea Therapeutics Corp.'s latest annual total debt in 2023 was 81.68 Thousand USD , down -91.19% from previous year.
  • Pasithea Therapeutics Corp.'s latest quarterly total debt in 2024 Q2 was - USD , down -100.0% from previous quarter.
  • Pasithea Therapeutics Corp. reported annual total debt of 926.88 Thousand USD in 2022, down 0.0% from previous year.
  • Pasithea Therapeutics Corp. reported annual total debt of - USD in 2021, down 0.0% from previous year.
  • Pasithea Therapeutics Corp. reported quarterly total debt of - USD for 2024 Q2, down -100.0% from previous quarter.
  • Pasithea Therapeutics Corp. reported quarterly total debt of 385.28 Thousand USD for 2023 Q3, down -31.09% from previous quarter.

Annual Total Debt Chart of Pasithea Therapeutics Corp. (2023 - 2020)

Historical Annual Total Debt of Pasithea Therapeutics Corp. (2023 - 2020)

Year Total Debt Total Debt Growth
2023 81.68 Thousand USD -91.19%
2022 926.88 Thousand USD 0.0%
2021 - USD 0.0%
2020 - USD 0.0%

Peer Total Debt Comparison of Pasithea Therapeutics Corp.

Name Total Debt Total Debt Difference
NeuroSense Therapeutics Ltd. 142 Thousand USD 42.479%
Psyence Biomedical Ltd. 7.65 Million USD 98.933%
XOMA Corporation 124.45 Million USD 99.934%
Mesoblast Limited 118.92 Million USD 99.931%
Xeris Biopharma Holdings, Inc. 229.19 Million USD 99.964%
Aptorum Group Limited 3.36 Million USD 97.571%
Qualigen Therapeutics, Inc. 1.29 Million USD 93.713%
HilleVax, Inc. 51.19 Million USD 99.84%
Rocket Pharmaceuticals, Inc. 25.04 Million USD 99.674%
Corbus Pharmaceuticals Holdings, Inc. 20.88 Million USD 99.609%
Precision BioSciences, Inc. 31.26 Million USD 99.739%
Dyadic International, Inc. 136.92 Thousand USD 40.349%
Intensity Therapeutics, Inc. 158 Thousand USD 48.304%
IDEAYA Biosciences, Inc. 2.87 Million USD 97.156%
Eton Pharmaceuticals, Inc. 5.45 Million USD 98.503%
VYNE Therapeutics Inc. 214 Thousand USD 61.832%
EyePoint Pharmaceuticals, Inc. 5.46 Million USD 98.506%
Adaptive Biotechnologies Corporation 229.43 Million USD 99.964%
Tenaya Therapeutics, Inc. 12.42 Million USD 99.343%
IGM Biosciences, Inc. 40.5 Million USD 99.798%
Opthea Limited 200.62 Million USD 99.959%
Milestone Pharmaceuticals Inc. 51.77 Million USD 99.842%
Abeona Therapeutics Inc. 5.4 Million USD 98.487%
Tonix Pharmaceuticals Holding Corp. 9.81 Million USD 99.168%
Ligand Pharmaceuticals Incorporated 6.16 Million USD 98.675%
NextCure, Inc. 6.6 Million USD 98.763%
Inhibikase Therapeutics, Inc. 622 Thousand USD 86.868%
Ovid Therapeutics Inc. 46 Million USD 99.822%
CASI Pharmaceuticals, Inc. 21.23 Million USD 99.615%
Arcturus Therapeutics Holdings Inc. 30.21 Million USD 99.73%
Syros Pharmaceuticals, Inc. 62.07 Million USD 99.868%
Senti Biosciences, Inc. 37.66 Million USD 99.783%
Apollomics, Inc. 4.66 Million USD 98.248%
PureTech Health plc 25.51 Million USD 99.68%
Oncternal Therapeutics, Inc. 318 Thousand USD 74.314%
Barinthus Biotherapeutics plc 12.97 Million USD 99.371%
Kymera Therapeutics, Inc. 84.67 Million USD 99.904%
ChromaDex Corporation 3.27 Million USD 97.507%
Monopar Therapeutics Inc. - USD -Infinity%
Akebia Therapeutics, Inc. 104.18 Million USD 99.922%
Sangamo Therapeutics, Inc. 38.1 Million USD 99.786%
Dermata Therapeutics, Inc. - USD -Infinity%
Gritstone bio, Inc. 104.77 Million USD 99.922%
Virpax Pharmaceuticals, Inc. - USD -Infinity%
Fate Therapeutics, Inc. 103.53 Million USD 99.921%
BioXcel Therapeutics, Inc. 101.38 Million USD 99.919%
Fortress Biotech, Inc. 88.59 Million USD 99.908%
Checkpoint Therapeutics, Inc. - USD -Infinity%
Atossa Therapeutics, Inc. - USD -Infinity%
Lyell Immunopharma, Inc. 63.16 Million USD 99.871%
Celcuity Inc. 37.44 Million USD 99.782%
ContextLogic Inc. 6 Million USD 98.639%
GH Research PLC 343 Thousand USD 76.187%
HOOKIPA Pharma Inc. 6.55 Million USD 98.755%
Cassava Sciences, Inc. - USD -Infinity%
Cyclacel Pharmaceuticals, Inc. 37 Thousand USD -120.757%
ImmuCell Corporation 11.96 Million USD 99.318%
Amarin Corporation plc 8.73 Million USD 99.065%
TG Therapeutics, Inc. 110.79 Million USD 99.926%
X4 Pharmaceuticals, Inc. 58.28 Million USD 99.86%
Acelyrin, Inc. 1.19 Million USD 93.159%
BriaCell Therapeutics Corp. - USD -Infinity%
Seer, Inc. 28.25 Million USD 99.711%
Novavax, Inc. 280.63 Million USD 99.971%
Phathom Pharmaceuticals, Inc. 139.03 Million USD 99.941%
Jazz Pharmaceuticals plc 5.79 Billion USD 99.999%
AnaptysBio, Inc. 17.81 Million USD 99.541%
Aptevo Therapeutics Inc. 5.39 Million USD 98.487%
PMV Pharmaceuticals, Inc. 13.28 Million USD 99.385%
AbCellera Biologics Inc. 77.38 Million USD 99.894%
CorMedix Inc. 667.63 Thousand USD 87.766%
Cartesian Therapeutics, Inc. 10.95 Million USD 99.254%
Marker Therapeutics, Inc. - USD -Infinity%
Regeneron Pharmaceuticals, Inc. 2.7 Billion USD 99.997%
Aptose Biosciences Inc. 1 Million USD 91.911%
ZyVersa Therapeutics, Inc. 8656.00 USD -843.623%
Soligenix, Inc. 3.49 Million USD 97.663%
Century Therapeutics, Inc. 48.17 Million USD 99.83%
Arrowhead Pharmaceuticals, Inc. 115.17 Million USD 99.929%
TransCode Therapeutics, Inc. 450.57 Thousand USD 81.872%
Kura Oncology, Inc. 17.2 Million USD 99.525%
RAPT Therapeutics, Inc. 6.9 Million USD 98.817%
Ardelyx, Inc. 55.98 Million USD 99.854%
Ainos, Inc. 5.96 Million USD 98.63%
TScan Therapeutics, Inc. 92.43 Million USD 99.912%
Ocean Biomedical, Inc. 2.15 Million USD 96.201%
Prothena Corporation plc 11.83 Million USD 99.31%
CytomX Therapeutics, Inc. 13.97 Million USD 99.415%
Autolus Therapeutics plc 52.96 Million USD 99.846%
Mineralys Therapeutics, Inc. - USD -Infinity%
Adaptimmune Therapeutics plc 25.23 Million USD 99.676%
Eterna Therapeutics Inc. 41.84 Million USD 99.805%
Celularity Inc. 65.41 Million USD 99.875%
Rallybio Corporation 392 Thousand USD 79.163%
GRI Bio, Inc. 14 Thousand USD -483.429%
Xenetic Biosciences, Inc. - USD -Infinity%
Omeros Corporation 338.28 Million USD 99.976%
INmune Bio, Inc. 10.43 Million USD 99.217%
Heron Therapeutics, Inc. 179.62 Million USD 99.955%
SAB Biotherapeutics, Inc. 5.9 Million USD 98.617%
Entero Therapeutics, Inc. 826.84 Thousand USD 90.121%
Humacyte, Inc. 58.1 Million USD 99.859%
Atara Biotherapeutics, Inc. 57.87 Million USD 99.859%
Coherus BioSciences, Inc. 480.84 Million USD 99.983%
Immunocore Holdings plc 84.03 Million USD 99.903%
Cocrystal Pharma, Inc. 1.85 Million USD 95.592%
Verastem, Inc. 41.55 Million USD 99.803%
Pliant Therapeutics, Inc. 11.37 Million USD 99.282%
Histogen Inc. 4.62 Million USD 98.233%
Surrozen, Inc. 3.37 Million USD 97.583%
Blueprint Medicines Corporation 774.12 Million USD 99.989%
Organovo Holdings, Inc. 1.39 Million USD 94.141%
Lixte Biotechnology Holdings, Inc. - USD -Infinity%
IO Biotech, Inc. 2.49 Million USD 96.725%
MEI Pharma, Inc. - USD -Infinity%
GT Biopharma, Inc. 58 Thousand USD -40.828%
Centessa Pharmaceuticals plc 84.58 Million USD 99.903%
Hepion Pharmaceuticals, Inc. 209.02 Thousand USD 60.922%
Cabaletta Bio, Inc. 5.01 Million USD 98.372%
Summit Therapeutics Inc. 106.09 Million USD 99.923%
Alaunos Therapeutics, Inc. - USD -Infinity%
Marinus Pharmaceuticals, Inc. 110.35 Million USD 99.926%
BioRestorative Therapies, Inc. 162.31 Thousand USD 49.679%
Turnstone Biologics Corp. 3.21 Million USD 97.459%
Pulmatrix, Inc. 8.75 Million USD 99.067%
Synaptogenix, Inc. - USD -Infinity%
Tiziana Life Sciences Ltd 247 Thousand USD 66.931%
Aurinia Pharmaceuticals Inc. 97.6 Million USD 99.916%
Vigil Neuroscience, Inc. 13.85 Million USD 99.41%
Intellia Therapeutics, Inc. 115.34 Million USD 99.929%
Cytokinetics, Incorporated 755.77 Million USD 99.989%
Exelixis, Inc. 189.94 Million USD 99.957%
Nurix Therapeutics, Inc. 30.61 Million USD 99.733%
Apellis Pharmaceuticals, Inc. 110.92 Million USD 99.926%
Evogene Ltd. 1.13 Million USD 92.822%
Replimune Group, Inc. 75.86 Million USD 99.892%
PDS Biotechnology Corporation 23.85 Million USD 99.658%
Hoth Therapeutics, Inc. 55.16 Thousand USD -48.065%
Jasper Therapeutics, Inc. 2.78 Million USD 97.068%
ESSA Pharma Inc. 80.32 Thousand USD -1.683%
TNF Pharmaceuticals, Inc. 48.87 Thousand USD -67.137%
BioLineRx Ltd. 11.59 Million USD 99.295%
Avid Bioservices, Inc. 207.83 Million USD 99.961%
Insmed Incorporated 1.2 Billion USD 99.993%
VistaGen Therapeutics, Inc. 2.12 Million USD 96.147%
Zentalis Pharmaceuticals, Inc. 45.77 Million USD 99.822%
Sagimet Biosciences Inc. 65 Thousand USD -25.662%
MediWound Ltd. 6.71 Million USD 98.783%
MiMedx Group, Inc. 48.09 Million USD 99.83%
OmniAb, Inc. 25.56 Million USD 99.68%
Alector, Inc. 38.91 Million USD 99.79%
Seres Therapeutics, Inc. 213.93 Million USD 99.962%
PTC Therapeutics, Inc. 415.02 Million USD 99.98%
Mereo BioPharma Group plc 5.95 Million USD 98.628%
Zai Lab Limited 15.15 Million USD 99.461%
Revance Therapeutics, Inc. 478.43 Million USD 99.983%
Syndax Pharmaceuticals, Inc. 1.63 Million USD 95.004%
Aura Biosciences, Inc. 19.55 Million USD 99.582%
Immunic, Inc. 1.33 Million USD 93.877%
Dyne Therapeutics, Inc. 27.41 Million USD 99.702%
Tarsus Pharmaceuticals, Inc. 31.73 Million USD 99.743%
Veracyte, Inc. 12.63 Million USD 99.353%
InMed Pharmaceuticals Inc. 644.86 Million USD 99.987%
FibroGen, Inc. 170.45 Million USD 99.952%
SeaStar Medical Holding Corporation 9.08 Million USD 99.101%
Allakos Inc. 41.46 Million USD 99.803%
scPharmaceuticals Inc. 40.26 Million USD 99.797%
Fulcrum Therapeutics, Inc. 10.82 Million USD 99.245%
Corcept Therapeutics Incorporated 151 Thousand USD 45.907%
Adial Pharmaceuticals, Inc. - USD -Infinity%
NLS Pharmaceutics AG 1.63 Million USD 95.0%
Sonnet BioTherapeutics Holdings, Inc. 203.91 Thousand USD 59.943%
Amylyx Pharmaceuticals, Inc. 4.23 Million USD 98.072%
Precigen, Inc. 7.09 Million USD 98.849%
Fortrea Holdings Inc. 1.67 Billion USD 99.995%
KalVista Pharmaceuticals, Inc. 7.31 Million USD 98.884%
Incyte Corporation 38.28 Million USD 99.787%
Alzamend Neuro, Inc. 300.71 Thousand USD 72.838%
Cara Therapeutics, Inc. 43.16 Million USD 99.811%
XBiotech Inc. - USD -Infinity%
Aligos Therapeutics, Inc. 11.13 Million USD 99.267%
Jasper Therapeutics, Inc. 2.78 Million USD 97.068%
Reviva Pharmaceuticals Holdings, Inc. - USD -Infinity%
CRISPR Therapeutics AG 238.63 Million USD 99.966%
Akero Therapeutics, Inc. 26.04 Million USD 99.686%
Eliem Therapeutics, Inc. 349 Thousand USD 76.596%
Lyra Therapeutics, Inc. 26.88 Million USD 99.696%
Foghorn Therapeutics Inc. 45.07 Million USD 99.819%
Agenus Inc. 350.24 Million USD 99.977%
Kiora Pharmaceuticals, Inc. 106.89 Thousand USD 23.586%
Y-mAbs Therapeutics, Inc. 1.41 Million USD 94.244%
Theravance Biopharma, Inc. 45.23 Million USD 99.819%
Ultragenyx Pharmaceutical Inc. 43.16 Million USD 99.811%
Metagenomi, Inc. Common Stock 48.22 Million USD 99.831%
Lexaria Bioscience Corp. 163.96 Thousand USD 50.185%
BioCryst Pharmaceuticals, Inc. 848.71 Million USD 99.99%
UroGen Pharma Ltd. 100.21 Million USD 99.918%
Gain Therapeutics, Inc. 1.02 Million USD 92.05%
Sutro Biopharma, Inc. 182.74 Million USD 99.955%
Creative Medical Technology Holdings, Inc. 14.19 Thousand USD -475.454%
Lisata Therapeutics, Inc. 305 Thousand USD 73.22%
Chemomab Therapeutics Ltd. 392 Thousand USD 79.163%
Stoke Therapeutics, Inc. 6.83 Million USD 98.805%
Chimerix, Inc. 2.14 Million USD 96.19%
Reneo Pharmaceuticals, Inc. 973 Thousand USD 91.605%
Outlook Therapeutics, Inc. 35.55 Million USD 99.77%
60 Degrees Pharmaceuticals, Inc. 172.67 Thousand USD 52.697%
Pluri Inc. 29.61 Million USD 99.724%
Cue Biopharma, Inc. 14.69 Million USD 99.444%
MeiraGTx Holdings plc 89.26 Million USD 99.908%
Aprea Therapeutics, Inc. - USD -Infinity%
Cadrenal Therapeutics, Inc. Common Stock 21.35 Thousand USD -282.576%
Cidara Therapeutics, Inc. 4.87 Million USD 98.325%
ProMIS Neurosciences, Inc. - USD -Infinity%
CalciMedica, Inc. - USD -Infinity%
Scholar Rock Holding Corporation 61.81 Million USD 99.868%
Sana Biotechnology, Inc. 104.09 Million USD 99.922%
Elicio Therapeutics, Inc. 6.91 Million USD 98.819%
NLS Pharmaceutics AG 1.63 Million USD 95.0%
Adlai Nortye Ltd. American Depositary Shares 31.54 Million USD 99.741%
Nutriband Inc. 241.28 Thousand USD 66.148%
Protara Therapeutics, Inc. 5.46 Million USD 98.506%
Vor Biopharma Inc. 35.66 Million USD 99.771%
Roivant Sciences Ltd. 499.74 Million USD 99.984%
ProKidney Corp. 4.41 Million USD 98.149%
Applied Therapeutics, Inc. 1.22 Million USD 93.338%
Daré Bioscience, Inc. 5.31 Million USD 98.464%
BridgeBio Pharma, Inc. 1.73 Billion USD 99.995%
Titan Pharmaceuticals, Inc. 565 Thousand USD 85.543%
Bicycle Therapeutics plc 44.95 Million USD 99.818%
Tango Therapeutics, Inc. 38.92 Million USD 99.79%
Galectin Therapeutics Inc. 71.8 Million USD 99.886%
Revolution Medicines, Inc. Warrant 87.94 Million USD 99.907%
Atai Life Sciences N.V. 16.47 Million USD 99.504%
Renovaro Biosciences Inc. 2.45 Million USD 96.667%
Aerovate Therapeutics, Inc. 675 Thousand USD 87.899%
MediciNova, Inc. 215.92 Thousand USD 62.172%
Praxis Precision Medicines, Inc. 2.49 Million USD 96.726%
Cardio Diagnostics Holdings, Inc. 1.26 Million USD 93.523%
GeoVax Labs, Inc. - USD -Infinity%
Protagonist Therapeutics, Inc. 1.14 Million USD 92.841%
Axsome Therapeutics, Inc. 186.37 Million USD 99.956%
Biomea Fusion, Inc. 10.29 Million USD 99.207%
RenovoRx, Inc. - USD -Infinity%
Erasca, Inc. 55.85 Million USD 99.854%
Cullinan Oncology, Inc. 3.59 Million USD 97.725%
NRx Pharmaceuticals, Inc. 9.16 Million USD 99.108%
4D Molecular Therapeutics, Inc. 14.67 Million USD 99.443%
Kiniksa Pharmaceuticals, Ltd. 12.25 Million USD 99.334%
bluebird bio, Inc. 330.32 Million USD 99.975%
Ventyx Biosciences, Inc. 12.5 Million USD 99.347%
Pieris Pharmaceuticals, Inc. - USD -Infinity%
Imunon, Inc. 1.62 Million USD 94.973%
BioMarin Pharmaceutical Inc. 1.13 Billion USD 99.993%
BioAtla, Inc. 2.46 Million USD 96.68%
Allogene Therapeutics, Inc. 95.12 Million USD 99.914%
Larimar Therapeutics, Inc. 5.54 Million USD 98.527%
DBV Technologies S.A. 14.38 Million USD 99.432%
Fortress Biotech, Inc. 88.59 Million USD 99.908%
Avidity Biosciences, Inc. 9.85 Million USD 99.171%
Kezar Life Sciences, Inc. 18.93 Million USD 99.569%
aTyr Pharma, Inc. 15.09 Million USD 99.459%
Viridian Therapeutics, Inc. 21.04 Million USD 99.612%
EyeGate Pharmaceuticals, Inc. 326.49 Thousand USD 74.983%
Galecto, Inc. 249 Thousand USD 67.197%
Akari Therapeutics, Plc - USD -Infinity%
Tevogen Bio Holdings Inc. 1.63 Million USD 94.994%
Halozyme Therapeutics, Inc. 1.49 Billion USD 99.995%
Lexicon Pharmaceuticals, Inc. 106.06 Million USD 99.923%
Entera Bio Ltd. 390 Thousand USD 79.056%
Travere Therapeutics, Inc. 404.78 Million USD 99.98%
Sensei Biotherapeutics, Inc. 6.2 Million USD 98.684%
Xencor, Inc. 83.43 Million USD 99.902%
Orchestra BioMed Holdings, Inc. 1.68 Million USD 95.158%
Spruce Biosciences, Inc. 4.6 Million USD 98.228%
Coeptis Therapeutics Holdings, Inc. 1.22 Million USD 93.328%
Vanda Pharmaceuticals Inc. 9.4 Million USD 99.131%
Lexaria Bioscience Corp. 163.96 Thousand USD 50.185%
Portage Biotech Inc. 47 Thousand USD -73.787%
Cardio Diagnostics Holdings, Inc. 1.26 Million USD 93.523%
Olema Pharmaceuticals, Inc. 2.41 Million USD 96.621%
OncoCyte Corporation 2.86 Million USD 97.153%
Processa Pharmaceuticals, Inc. 150.55 Thousand USD 45.747%
Purple Biotech Ltd. 351 Thousand USD 76.729%
CollPlant Biotechnologies Ltd. 3.15 Million USD 97.414%
Onconetix, Inc. 9.88 Million USD 99.174%
MacroGenics, Inc. 33.97 Million USD 99.76%
Tharimmune, Inc. - USD -Infinity%
Genprex, Inc. - USD -Infinity%
Apogee Therapeutics, Inc. 2.03 Million USD 95.984%
Neumora Therapeutics, Inc. Common Stock 5.23 Million USD 98.439%
Ocuphire Pharma, Inc. - USD -Infinity%
Prime Medicine, Inc. 13.63 Million USD 99.401%
Aditxt, Inc. 18.21 Million USD 99.552%
XTL Biopharmaceuticals Ltd. - USD -Infinity%
Virios Therapeutics, Inc. - USD -Infinity%
OKYO Pharma Limited - USD -Infinity%
Savara Inc. 26.73 Million USD 99.695%
Curis, Inc. 2.79 Million USD 97.077%
Carmell Therapeutics Corporation 2.13 Million USD 96.177%
Adagene Inc. 22.3 Million USD 99.634%
Achieve Life Sciences, Inc. 16.73 Million USD 99.512%
BeiGene, Ltd. 930.18 Million USD 99.991%
Inhibrx Biosciences, Inc. 210.14 Million USD 99.961%
GlycoMimetics, Inc. 808.4 Thousand USD 89.896%
Maravai LifeSciences Holdings, Inc. 610.96 Million USD 99.987%
Protagenic Therapeutics, Inc. - USD -Infinity%
SciSparc Ltd. 76 Thousand USD -7.474%
Protagenic Therapeutics, Inc. - USD -Infinity%
Vincerx Pharma, Inc. 2.5 Million USD 96.735%
Revelation Biosciences, Inc. - USD -Infinity%
Minerva Neurosciences, Inc. 82.01 Million USD 99.9%
Fresh Tracks Therapeutics, Inc. - USD -Infinity%
Arcutis Biotherapeutics, Inc. 205.91 Million USD 99.96%
Acrivon Therapeutics, Inc. Common Stock 4.64 Million USD 98.241%
Alnylam Pharmaceuticals, Inc. 2.68 Billion USD 99.997%
ADMA Biologics, Inc. 141.41 Million USD 99.942%
Rigel Pharmaceuticals, Inc. 60.57 Million USD 99.865%
Clene Inc. 32.16 Million USD 99.746%
Celldex Therapeutics, Inc. 2.54 Million USD 96.787%
Cogent Biosciences, Inc. 18.85 Million USD 99.567%
Boundless Bio, Inc. Common Stock 2.19 Million USD 96.279%
Recursion Pharmaceuticals, Inc. 50.67 Million USD 99.839%
Adicet Bio, Inc. 20.92 Million USD 99.61%
Contineum Therapeutics, Inc. Class A Common Stock 193.19 Million USD 99.958%
Absci Corporation 15.95 Million USD 99.488%
Estrella Immunopharma, Inc. - USD -Infinity%
Quantum-Si incorporated 15.3 Million USD 99.466%
Acurx Pharmaceuticals, Inc. - USD -Infinity%
Voyager Therapeutics, Inc. 20.29 Million USD 99.597%
Surrozen, Inc. 3.37 Million USD 97.583%
Generation Bio Co. 97.89 Million USD 99.917%
Astria Therapeutics, Inc. 329 Thousand USD 75.173%
Caribou Biosciences, Inc. 27.48 Million USD 99.703%
Black Diamond Therapeutics, Inc. 25.29 Million USD 99.677%
Janux Therapeutics, Inc. 24.54 Million USD 99.667%
Invivyd, Inc. 2.16 Million USD 96.227%
Cingulate Inc. 3.13 Million USD 97.395%
Relay Therapeutics, Inc. 53.46 Million USD 99.847%
Quoin Pharmaceuticals, Ltd. 3523.73 USD -2217.998%
Tenax Therapeutics, Inc. 500.9 Thousand USD 83.693%
Spero Therapeutics, Inc. 5.54 Million USD 98.526%
Jaguar Health, Inc. 35.86 Million USD 99.772%
Artelo Biosciences, Inc. 63 Thousand USD -29.651%
2seventy bio, Inc. 256.67 Million USD 99.968%
Clearside Biomedical, Inc. 43 Million USD 99.81%
Terns Pharmaceuticals, Inc. 603 Thousand USD 86.454%
ACADIA Pharmaceuticals Inc. 57.2 Million USD 99.857%
Capricor Therapeutics, Inc. 5.61 Million USD 98.545%
Citius Pharmaceuticals, Inc. 481.24 Thousand USD 83.027%
Relmada Therapeutics, Inc. - USD -Infinity%
Kronos Bio, Inc. 28.27 Million USD 99.711%
Innoviva, Inc. 449.07 Million USD 99.982%
Bolt Biotherapeutics, Inc. 20.21 Million USD 99.596%
Entrada Therapeutics, Inc. 68.23 Million USD 99.88%
ALX Oncology Holdings Inc. 17.19 Million USD 99.525%
Vir Biotechnology, Inc. 124.54 Million USD 99.934%
Evaxion Biotech A/S 10.86 Million USD 99.249%
Ocular Therapeutix, Inc. 83.38 Million USD 99.902%
Verve Therapeutics, Inc. 74.9 Million USD 99.891%
Tyra Biosciences, Inc. 6.49 Million USD 98.743%
Galmed Pharmaceuticals Ltd. 41 Thousand USD -99.22%
Unity Biotechnology, Inc. 26.99 Million USD 99.697%
Connect Biopharma Holdings Limited 465 Thousand USD 82.434%
Clearmind Medicine Inc. - USD -Infinity%
AlloVir, Inc. 27.42 Million USD 99.702%
ORIC Pharmaceuticals, Inc. 10.21 Million USD 99.2%
Catalyst Pharmaceuticals, Inc. 3.55 Million USD 97.704%
CERo Therapeutics Holdings, Inc. 1.55 Million USD 94.747%
Viking Therapeutics, Inc. 1.26 Million USD 93.517%
Keros Therapeutics, Inc. 14.44 Million USD 99.435%
SELLAS Life Sciences Group, Inc. 906 Thousand USD 90.985%
Crinetics Pharmaceuticals, Inc. 51.72 Million USD 99.842%
ImmunityBio, Inc. 883.67 Million USD 99.991%
Korro Bio, Inc. 33.2 Million USD 99.754%
C4 Therapeutics, Inc. 70.97 Million USD 99.885%
Kineta, Inc. 1.31 Million USD 93.798%
Lantern Pharma Inc. 234.47 Thousand USD 65.164%
BioVie Inc. 6.11 Million USD 98.663%
Codexis, Inc. 22.36 Million USD 99.635%
Celularity Inc. 65.41 Million USD 99.875%
Eledon Pharmaceuticals, Inc. 383 Thousand USD 78.674%
Virax Biolabs Group Limited 224.3 Thousand USD 63.584%
Kodiak Sciences Inc. 181.63 Million USD 99.955%
Cibus, Inc. 24.62 Million USD 99.668%
Annexon, Inc. 31.35 Million USD 99.739%
Assembly Biosciences, Inc. 2.34 Million USD 96.512%
Moderna, Inc. - USD -Infinity%
Ionis Pharmaceuticals, Inc. 1.45 Billion USD 99.994%
Adverum Biotechnologies, Inc. 75.03 Million USD 99.891%
Avalo Therapeutics, Inc. 3.9 Million USD 97.907%
Immix Biopharma, Inc. - USD -Infinity%
Eyenovia, Inc. 16.1 Million USD 99.493%
Puma Biotechnology, Inc. 111.49 Million USD 99.927%
Monte Rosa Therapeutics, Inc. 46.03 Million USD 99.823%
Wave Life Sciences Ltd. 32.11 Million USD 99.746%
Conduit Pharmaceuticals Inc. 985 Thousand USD 91.708%
Xilio Therapeutics, Inc. 11.45 Million USD 99.287%
Alkermes plc 290.73 Million USD 99.972%
Arcellx, Inc. 97.62 Million USD 99.916%
Moolec Science SA 2.64 Million USD 96.912%
Cardiff Oncology, Inc. 2.14 Million USD 96.199%
LAVA Therapeutics N.V. 6.31 Million USD 98.706%
Enanta Pharmaceuticals, Inc. 26.51 Million USD 99.692%
Regulus Therapeutics Inc. 3.1 Million USD 97.367%
Atea Pharmaceuticals, Inc. 2.4 Million USD 96.6%
Compass Therapeutics, Inc. 1.73 Million USD 95.287%
Greenwich LifeSciences, Inc. - USD -Infinity%
Humacyte, Inc. 58.1 Million USD 99.859%
Acumen Pharmaceuticals, Inc. 28.48 Million USD 99.713%
Geron Corporation 85.89 Million USD 99.905%
Verrica Pharmaceuticals Inc. 45.51 Million USD 99.821%
Avenue Therapeutics, Inc. - USD -Infinity%
Royalty Pharma plc 6.13 Billion USD 99.999%
TFF Pharmaceuticals, Inc. 115.25 Thousand USD 29.13%
Notable Labs, Ltd. 2.04 Million USD 96.014%
Mersana Therapeutics, Inc. 33.83 Million USD 99.759%
Structure Therapeutics Inc. 5.45 Million USD 98.502%
IN8bio, Inc. 4.89 Million USD 98.331%
89bio, Inc. 27.1 Million USD 99.699%
DiaMedica Therapeutics Inc. 400 Thousand USD 79.58%
Vera Therapeutics, Inc. 53.7 Million USD 99.848%
Acasti Pharma Inc. - USD -Infinity%
Genelux Corporation 2.51 Million USD 96.757%
Trevi Therapeutics, Inc. 1.33 Million USD 93.895%
Liquidia Corporation 3.5 Million USD 97.668%
Mustang Bio, Inc. 2.49 Million USD 96.73%
Immunovant, Inc. 138 Thousand USD 40.812%
Vericel Corporation 88.14 Million USD 99.907%
Quantum-Si incorporated 15.3 Million USD 99.466%
Arbutus Biopharma Corporation 8.72 Million USD 99.063%
XOMA Corporation 124.45 Million USD 99.934%
ARS Pharmaceuticals, Inc. 274 Thousand USD 70.19%
MiNK Therapeutics, Inc. - USD -Infinity%
Pasithea Therapeutics Corp. 81.68 Thousand USD 0.0%
Alpha Tau Medical Ltd. 13.27 Million USD 99.385%
Vaxcyte, Inc. 29.22 Million USD 99.721%
Xenon Pharmaceuticals Inc. 10.9 Million USD 99.251%
Estrella Immunopharma, Inc. - USD -Infinity%
NeuroBo Pharmaceuticals, Inc. 203 Thousand USD 59.764%
Tempest Therapeutics, Inc. 20.66 Million USD 99.605%
Sol-Gel Technologies Ltd. 1.65 Million USD 95.059%
Rhythm Pharmaceuticals, Inc. 1.26 Million USD 93.517%
Soleno Therapeutics, Inc. 403 Thousand USD 79.732%
Enlivex Therapeutics Ltd. 1.03 Million USD 92.085%
PepGen Inc. 20.1 Million USD 99.594%
Moleculin Biotech, Inc. 574 Thousand USD 85.77%
United Therapeutics Corporation 700 Million USD 99.988%
Solid Biosciences Inc. 26.26 Million USD 99.689%
BriaCell Therapeutics Corp. - USD -Infinity%
Conduit Pharmaceuticals Inc. 985 Thousand USD 91.708%
Immuneering Corporation 4.46 Million USD 98.17%
Lixte Biotechnology Holdings, Inc. - USD -Infinity%
Silo Pharma, Inc. - USD -Infinity%
Telomir Pharmaceuticals, Inc. Common Stock 101 Thousand USD 19.129%
Belite Bio, Inc 886 Thousand USD 90.781%
Pharming Group N.V. 171.54 Million USD 99.952%
Reviva Pharmaceuticals Holdings, Inc. - USD -Infinity%
Bionomics Limited 239.61 Million USD 99.966%
Pyxis Oncology, Inc. 21.33 Million USD 99.617%
uniQure N.V. 138.4 Million USD 99.941%
Windtree Therapeutics, Inc. 16.83 Million USD 99.515%
GeoVax Labs, Inc. - USD -Infinity%
Poseida Therapeutics, Inc. 85.42 Million USD 99.904%
Altimmune, Inc. 671 Thousand USD 87.827%
Anebulo Pharmaceuticals, Inc. - USD -Infinity%
Alpha Tau Medical Ltd. 13.27 Million USD 99.385%
Peak Bio, Inc. 10.72 Million USD 99.238%
SeaStar Medical Holding Corporation 9.08 Million USD 99.101%
FibroBiologics, Inc. Common Stock 1.74 Million USD 95.325%
Benitec Biopharma Inc. 284 Thousand USD 71.239%
Zura Bio Limited - USD -Infinity%
Amicus Therapeutics, Inc. 445.05 Million USD 99.982%
Salarius Pharmaceuticals, Inc. 289.64 Thousand USD 71.8%
Compugen Ltd. 1.35 Million USD 93.954%
Elevai Labs, Inc. Common Stock 210.48 Thousand USD 61.195%
argenx SE 20 Million USD 99.592%
Zevra Therapeutics, Inc. 42.76 Million USD 99.809%
Nuvectis Pharma, Inc. - USD -Infinity%
Spyre Therapeutics, Inc. 84.55 Million USD 99.903%
NKGen Biotech, Inc. Common Stock 19.92 Million USD 99.59%
Madrigal Pharmaceuticals, Inc. 117.19 Million USD 99.93%
PolyPid Ltd. 11.77 Million USD 99.307%
Aileron Therapeutics, Inc. 91.45 Million USD 99.911%
Plus Therapeutics, Inc. 4.18 Million USD 98.046%
Forte Biosciences, Inc. - USD -Infinity%
Dianthus Therapeutics, Inc. 585 Thousand USD 86.038%
Instil Bio, Inc. 86.05 Million USD 99.905%
Elevation Oncology, Inc. 30.13 Million USD 99.729%
Immunome, Inc. 1.65 Million USD 95.05%
Verona Pharma plc 51.32 Million USD 99.841%
Enveric Biosciences, Inc. - USD -Infinity%
enGene Holdings Inc. Warrants 9.77 Million USD 99.165%
Shattuck Labs, Inc. 4.2 Million USD 98.056%
LENZ Therapeutics, Inc. 362 Thousand USD 77.436%
Design Therapeutics, Inc. 3.05 Million USD 97.322%
Leap Therapeutics, Inc. 262 Thousand USD 68.824%
Seelos Therapeutics, Inc. 14.22 Million USD 99.426%
Achilles Therapeutics plc 4.61 Million USD 98.23%
Fractyl Health, Inc. Common Stock 373.72 Million USD 99.978%
Rani Therapeutics Holdings, Inc. 30.09 Million USD 99.729%
MoonLake Immunotherapeutics 3.69 Million USD 97.791%
Beam Therapeutics Inc. 173.17 Million USD 99.953%
Moolec Science SA 2.64 Million USD 96.912%
Longboard Pharmaceuticals, Inc. 475 Thousand USD 82.804%
AEON Biopharma, Inc. 278 Thousand USD 70.619%
Aadi Bioscience, Inc. 7.02 Million USD 98.837%
Enliven Therapeutics, Inc. 335 Thousand USD 75.618%
Iovance Biotherapeutics, Inc. 75.86 Million USD 99.892%
Taysha Gene Therapies, Inc. 61.1 Million USD 99.866%
Inovio Pharmaceuticals, Inc. 30.2 Million USD 99.73%
Athira Pharma, Inc. 1.58 Million USD 94.847%
HCW Biologics Inc. 6.45 Million USD 98.734%
XOMA Corporation 124.45 Million USD 99.934%
NeurAxis, Inc. 224.26 Thousand USD 63.578%
Lumos Pharma, Inc. 6.58 Million USD 98.76%
enGene Holdings Inc. Common Stock 9.77 Million USD 99.165%
180 Life Sciences Corp. 1.32 Million USD 93.812%
Nektar Therapeutics 230.4 Million USD 99.965%
NKGen Biotech, Inc. Warrants 19.92 Million USD 99.59%
Opiant Pharmaceuticals, Inc. 17.08 Million USD 99.522%
Arvinas, Inc. 3.4 Million USD 97.598%
CERo Therapeutics Holdings, Inc. 1.55 Million USD 94.747%
Palisade Bio, Inc. 369 Thousand USD 77.864%
Nutriband Inc. 241.28 Thousand USD 66.148%
Tevogen Bio Holdings Inc. 1.63 Million USD 94.994%
CG Oncology, Inc. Common stock 826 Thousand USD 90.111%
Tourmaline Bio, Inc. 415 Thousand USD 80.318%
Merus N.V. 12.16 Million USD 99.328%
Omega Therapeutics, Inc. 128.42 Million USD 99.936%
Neurogene Inc. 16.25 Million USD 99.498%
Mirum Pharmaceuticals, Inc. 308.14 Million USD 99.973%
Kintara Therapeutics, Inc. - USD -Infinity%
CervoMed Inc. - USD -Infinity%
CARGO Therapeutics, Inc. Common Stock 28.54 Million USD 99.714%
Sesen Bio, Inc. - USD -Infinity%
Quince Therapeutics, Inc. 13.81 Million USD 99.409%
Rezolute, Inc. 2.22 Million USD 96.334%
Clene Inc. 32.16 Million USD 99.746%
Indaptus Therapeutics, Inc. 175.05 Thousand USD 53.34%
BeyondSpring Inc. 3.99 Million USD 97.955%
Synlogic, Inc. 17.27 Million USD 99.527%
Allarity Therapeutics, Inc. 1.3 Million USD 93.717%
Phio Pharmaceuticals Corp. 35 Thousand USD -133.371%
Peak Bio, Inc. 10.72 Million USD 99.238%
Werewolf Therapeutics, Inc. 51.92 Million USD 99.843%
Krystal Biotech, Inc. 8.09 Million USD 98.991%
Karyopharm Therapeutics Inc. 177.01 Million USD 99.954%
SpringWorks Therapeutics, Inc. 7.05 Million USD 98.843%
Lipella Pharmaceuticals Inc. 136.59 Thousand USD 40.202%
MannKind Corporation 382.37 Million USD 99.979%
Ikena Oncology, Inc. 10.73 Million USD 99.239%
Cyclerion Therapeutics, Inc. - USD -Infinity%
Gyre Therapeutics, Inc. 409 Thousand USD 80.029%
Gossamer Bio, Inc. 212.46 Million USD 99.962%
CohBar, Inc. - USD -Infinity%
Cognition Therapeutics, Inc. 174 Thousand USD 53.057%
NRx Pharmaceuticals, Inc. 9.16 Million USD 99.108%
Legend Biotech Corporation 328.67 Million USD 99.975%
Mural Oncology plc 15 Million USD 99.456%
Disc Medicine, Inc. 2.1 Million USD 96.112%
Champions Oncology, Inc. 7.43 Million USD 98.901%
REGENXBIO Inc. 89.29 Million USD 99.909%
Ensysce Biosciences, Inc. 854.69 Thousand USD 90.443%
Anavex Life Sciences Corp. - USD -Infinity%
Cellectar Biosciences, Inc. 552.98 Thousand USD 85.229%
Edgewise Therapeutics, Inc. 5.41 Million USD 98.491%
Vaxart, Inc. 26.51 Million USD 99.692%
PharmaCyte Biotech, Inc. - USD -Infinity%
Aldeyra Therapeutics, Inc. 15.65 Million USD 99.478%
Cellectis S.A. 92.85 Million USD 99.912%
Longeveron Inc. 2.04 Million USD 95.998%
Repare Therapeutics Inc. 3.41 Million USD 97.605%
Sarepta Therapeutics, Inc. 1.39 Billion USD 99.994%
Inozyme Pharma, Inc. 46.59 Million USD 99.825%
Revolution Medicines, Inc. 87.94 Million USD 99.907%
Nymox Pharmaceutical Corporation 173 Thousand USD 52.786%
Third Harmonic Bio, Inc. 3.95 Million USD 97.934%
ArriVent BioPharma, Inc. Common Stock 317 Thousand USD 74.233%
AN2 Therapeutics, Inc. - USD -Infinity%
Anixa Biosciences, Inc. 175 Thousand USD 53.326%
Vertex Pharmaceuticals Incorporated 808.4 Million USD 99.99%
Denali Therapeutics Inc. 52.24 Million USD 99.844%
Revelation Biosciences, Inc. - USD -Infinity%
Veru Inc. 14.4 Million USD 99.433%
Corvus Pharmaceuticals, Inc. 1.37 Million USD 94.055%
Cingulate Inc. 3.13 Million USD 97.395%
Passage Bio, Inc. 26.29 Million USD 99.689%
Context Therapeutics Inc. - USD -Infinity%
Exicure, Inc. 6.66 Million USD 98.774%
Day One Biopharmaceuticals, Inc. 408 Thousand USD 79.98%
Oramed Pharmaceuticals Inc. 894 Thousand USD 90.864%
Scinai Immunotherapeutics Ltd. 20.56 Million USD 99.603%
Nuvalent, Inc. - USD -Infinity%
ABVC BioPharma, Inc. 2.45 Million USD 96.668%
Carisma Therapeutics, Inc. 3.12 Million USD 97.385%
Unicycive Therapeutics, Inc. 811 Thousand USD 89.928%
OmniAb, Inc. 25.56 Million USD 99.68%
Anew Medical, Inc. 1.6 Million USD 94.911%
Fennec Pharmaceuticals Inc. 29.58 Million USD 99.724%
Lipocine Inc. 17.16 Thousand USD -375.824%
Lexeo Therapeutics, Inc. Common Stock 11.63 Million USD 99.298%
Nautilus Biotechnology, Inc. 34.62 Million USD 99.764%
SAB Biotherapeutics, Inc. 5.9 Million USD 98.617%
G1 Therapeutics, Inc. 57.17 Million USD 99.857%
Bellerophon Therapeutics, Inc. 203 Thousand USD 59.764%
Sage Therapeutics, Inc. 5.16 Million USD 98.419%
Ocugen, Inc. 6.94 Million USD 98.823%
Mind Medicine (MindMed) Inc. 14.12 Million USD 99.422%
Q32 Bio Inc. 1.31 Million USD 93.803%
Brainstorm Cell Therapeutics Inc. 672 Thousand USD 87.845%
Alumis Inc. Common Stock 32.58 Million USD 99.749%
Equillium, Inc. 824 Thousand USD 90.087%
Kyverna Therapeutics, Inc. 9.07 Million USD 99.1%
Coya Therapeutics, Inc. - USD -Infinity%
CNS Pharmaceuticals, Inc. 300.8 Thousand USD 72.846%
Dominari Holdings Inc. 3.02 Million USD 97.303%
Edesa Biotech, Inc. 94.48 Thousand USD 13.554%
vTv Therapeutics Inc. 529 Thousand USD 84.56%
Bio-Techne Corporation 419.53 Million USD 99.981%
Agios Pharmaceuticals, Inc. 71.99 Million USD 99.887%
Harmony Biosciences Holdings, Inc. 193.56 Million USD 99.958%
Prelude Therapeutics Incorporated 16.88 Million USD 99.516%
Candel Therapeutics, Inc. 22.76 Million USD 99.641%
iTeos Therapeutics, Inc. 6.05 Million USD 98.652%
Nkarta, Inc. 88.33 Million USD 99.908%
BioCardia, Inc. 1.31 Million USD 93.789%
Iterum Therapeutics plc 19.5 Million USD 99.581%